Navigation Links
Drug Herceptin To Be Recommended To All Breast Cancer Patients

The drug Herceptin is to be recommended for breast cancer patients, who show positive for Her-2/neu. The presence of Her-2/neu indicates that the patient is positive, and they have a more resistant and active breast cancer, // about 30% of breast cancer women are Her-2/neu positive and the treatment for these patients with chemotherapy or anti-estrogen therapy such as Tamoxifen does not show any significant disease reduction. These patients should be given Herceptin drug for treatment.

Health Secretary Patricia Hewitt has already ordered the National Institute for Health and Clinical Excellence (NICE), the drugs watchdog, to fast track its assessment of the wider use of Herceptin. Herceptin targets a protein called HER2, which appears to be over-abundant in some women's breast cancers. Controversy also is occurring over the usage of Herceptin with some believing that Herceptin treatment is only useful during late stage breast cancer treatment, but campaigners and critics say that the drug is useful for also early stage breast cancer patients. Primary care trusts (PCTs) is currently to fund Herceptin treatment for women with early stage breast cancer, if they so wish, but campaigners say lack of funds and official approval mean that many women who could benefit are being denied the drug.

The Government is considering Her-2/neu testing to all breast cancer patients during their breast cancer surgery, using the tissue sample obtained during the surgery procedure. The company, which makes the drug, Roche, says the application for widening the use of Herceptin cannot be made any sooner than February because data from independent research has to be evaluated before it can be submitted. Keywords: Breast cancer, Herceptin, Her-2/neu, treatment, tamoxifen, chemotherapy, anti estrogen therapy, drug, anti-cancer drug, medication, primary care trust, stage of cancer, screening, controversy.

Page: 1

Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Herceptin Is A Possible Cure For Breast Cancer
3. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
4. £6000 to be refunded to Mrs. Leese for Herceptin treatmen
5. Wangaratta Community fundraising for Herceptin drug
6. Herceptin for Early Stage Breast cancer
7. Treatment of Breast Cancer with Herceptin for Nine Weeks
8. Herceptin is the cure for early stages of breast cancer?
9. 10-year-old Pleads, Herceptin For My Mum, Please
10. Norfolk PCTs To Offer Herceptin
11. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
Post Your Comments:

(Date:10/12/2015)... ... October 12, 2015 , ... To help ... its charitable donation to the National Breast Cancer Foundation. The National Breast Cancer ... breast cancer through early detection, education, and support services. , The annual campaign ...
(Date:10/12/2015)... ... October 12, 2015 , ... SQM Group ... a contact channel benchmarking study. Be a part of this insightful ... for improving customer experience, customer journey, contact channel execution and intelligence, workforce optimization, ...
(Date:10/12/2015)... ... ... Holcomb – Kreithen Plastic Surgery and MedSpa, PLLC (“Holcomb – Kreithen”), one of ... Surgery University,” an educational series of mini seminars covering aesthetic and plastic surgery options, ... Saturday, October 24, 2015. , The goal of the event is to provide hands-on ...
(Date:10/12/2015)... ... October 12, 2015 , ... The Asthma and ... Engagement Award by the Patient-Centered Outcomes Research Institute (PCORI) for a new project ... , The project, entitled “Training Patients with Asthma to Understand and Participate in ...
(Date:10/12/2015)... ... October 12, 2015 , ... International law firm Greenberg ... with the U.S. Biomedical Advanced Research and Development Authority (BARDA) reported to be ... ReCell® Autologous Cell Harvesting Device under a U.S. mass casualty preparedness program. ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... New York , October 12, 2015 ... (FMI) delivers key insights on the global vital signs monitoring ... Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025." The ... at a healthy CAGR of 9.5% and 9.2% in terms ... to factors, regarding which FMI offers major insights in detail ...
(Date:10/12/2015)... Oct. 12, 2015 Beginning October 1, 2015 ... Partner, the fastest growing practice management system for therapists, ... easily converts all patient diagnostic codes from the former ... --> --> Therapy Partner has ... mental health practitioners to easily understand the conversion to ...
(Date:10/12/2015)... , Oct. 12, 2015 Indivior PLC (LON: INDV) ... of Delaware granted the Company,s motion ... Abbreviated New Drug Application (ANDA) No. 205299 to market a ... and naloxone) Sublingual Film (CIII) in the United ... Since August 2013, Indivior has received Paragraph IV certifications ...
Breaking Medicine Technology: